Patent ID: 9657063
Date: 2017-05-23
CPC Classifications: A61K,A61P,C07K,C12N

Claim:
1. A porcine circovirus type 2 (PCV2) immunogenic composition, comprising an antigenic peptide, wherein the antigenic peptide consists of at least one of: (a) at least one recombinant peptide fragment of a PCV2 open reading frame 2 (ORF2) selected from the group consisting of a recombinant peptide consisting of amino acids 79-156 at the N-terminus of a PCV2 ORF2 of SEQ ID NO: 2, a recombinant peptide consisting of amino acids 157-233 at the N-terminus of the PCV2 ORF2 of SEQ ID NO: 2, a recombinant peptide consisting of amino acids 117-233 at the N-terminus of the PCV2 ORF2 of SEQ ID NO: 2, a recombinant peptide consisting of amino acids 79-233 at the N-terminus of the PCV2 ORF2 of SEQ ID NO: 2, a recombinant peptide consisting of amino acids 79-156 at the N-terminus of a PCV2 ORF2 of SEQ ID NO: 16, a recombinant peptide consisting of amino acids 157-233 at the N-terminus of the PCV2 ORF2 of SEQ ID NO: 16, a recombinant peptide consisting of amino acids 117-233 at the N-terminus of the PCV2 ORF2 of SEQ ID NO: 16, a recombinant peptide consisting of amino acids 79-233 at the N-terminus of the PCV2 ORF2 of SEQ ID NO: 16, a recombinant peptide consisting of amino acids 79-156 at the N-terminus of a PCV2 ORF2 of SEQ ID NO: 20, a recombinant peptide consisting of amino acids 157-233 at the N-terminus of the PCV2 ORF2 of SEQ ID NO: 20, a recombinant peptide consisting of amino acids 117-233 at the N-terminus of the PCV2 ORF2 of SEQ ID NO: 20, a recombinant peptide consisting of amino acids 79-233 at the N-terminus of the PCV2 ORF2 of SEQ ID NO: 20, a recombinant peptide consisting of amino acids 79-156 at the N-terminus of a PCV2 ORF2 of SEQ ID NO: 51, a recombinant peptide consisting of amino acids 157-233 at the N-terminus of the PCV2 ORF2 of SEQ ID NO: 51, a recombinant peptide consisting of amino acids 117-233 at the N-terminus of the PCV2 ORF2 of SEQ ID NO: 51, a recombinant peptide consisting of amino acids 79-233 at the N-terminus of the PCV2 ORF2 of SEQ ID NO: 51, a recombinant peptide consisting of amino acids 79-156 at the N-terminus of a PCV2 ORF2 of SEQ ID NO: 53, a recombinant peptide consisting of amino acids 157-233 at the N-terminus of the PCV2 ORF2 of SEQ ID NO: 53, a recombinant peptide consisting of amino acids 117-233 at the N-terminus of the PCV2 ORF2 of SEQ ID NO: 53, and a recombinant peptide consisting of amino acids 79-233 at the N-terminus of the PCV2 ORF2 of SEQ ID NO: 53; and (b) a recombinant fusion protein comprising, from the amino-terminus to the carboxyl-terminus of the recombinant fusion protein: a wherein the immunogenic composition does not include a peptide fragment consisting of amino acids 1-78 at the N-terminus of the PCV2 ORF2.